1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor

Journal of Endocrinology

Volumn 188, Issue 3, 2006, Pages 635-643

  Honjo, Yumiko ^a   Sasaki, Shigekazu ^a   Kobayashi, Yoshimasa ^a   Misawa, Hiroko ^a   Nakamura, Hirotoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILE SALT; CALCITRIOL; CELL NUCLEUS RECEPTOR; CHENODEOXYCHOLIC ACID; CHIMERIC PROTEIN; COLECALCIFEROL RECEPTOR; FARNESOID X RECEPTOR; GLUTATHIONE TRANSFERASE; LUCIFERASE; THYMIDINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SMALL HETERODIMER PARTNER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN HEPG2; DNA BINDING; EXPRESSION VECTOR; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CALCITRIOL; CELL LINE; CHENODEOXYCHOLIC ACID; DNA-BINDING PROTEINS; ESCHERICHIA COLI; FATTY ACID-BINDING PROTEINS; GENE DELETION; HUMANS; LIVER; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 33645235673     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06105     Document Type: Article

References (42)

1. Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ & Suchy FJ 2001 Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. Journal of Biological Chemistry 276 28857-28865.
2. 3: evidence of an enterohepatic circulation in man. Proceedings of the Society for Experimental Biology and Medicine 149 570-572.
3. Chawla A, Repa JJ, Evans RM & Mangelsdorf DJ 2001 Nuclear receptors and lipid physiology: opening the X-Files. Science 294 1866-1870.
4. 3 receptor. Biochemical and Biophysical Research Communications 218 902-907.
5. 3. PNAS 89 8097-8101.
6. DiStefano JJ 3rd, Nguyen TT & Yen YM 1993 Transfer kinetics of 3,5,3′-triiodothyronine and thyroxine from rat blood to large and small intestines, liver, and kidneys in vivo. Endocrinology 132 1735-1744.
7. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW et al. 1995 Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81 687-693.
8. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME et al. 2000 A regulatory cascade of the nuclear receptors Fxr, Shp-1, and Lrh-1 represses bile acid biosynthesis. Molecular Cell 6 517-526.
9. Goodwin B, Watson MA, Kim H, Miao J, Kemper JK & Kliewer SA 2003 Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor α. Molecular Endocrinology 17 386-394.
10. Green S, Issemann I & Sheer E 1988 A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Research 16 369.
11. Grober J, Zaghini I, Fujii H, Jones SA, Kliewer SA, Willson TM, Ono T & Besnard P 1999 Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. Journal of Biological Chemistry 274 29749-29754.
12. Halmos B, Szalay F, Cserniczky T, Nemesanszky E, Lakatos P, Barlage S, Schmitz G, Romics L & Csaszar A 2000 Association of primary biliary cirrhosis with vitamin D receptor Bsml genotype polymorphism in a Hungarian population. Digestive Diseases and Sciences 45 1091-1095.
13. Janowski BA, Willy PJ, Devi TR, Falck JR & Mangelsdorf DJ 1996 An oxysterol signalling pathway mediated by the nuclear receptor LXRα. Nature 383 728-731.
14. Kawai K, Hirota T, Muramatsu S, Tsuruta F, Ikeda T, Kobashi K & Nakamura KI 2000 Intestinal absorption and excretion of troglitazone sulphate, a major biliary metabolite of troglitazone. Xenobiotica 30 707-715.
15. Kawai K, Sasaki S, Morita H, Ito T, Suzuki S, Misawa H & Nakamura H 2004 Unliganded thyroid hormone receptor β1 represses liver X receptor α/oxysterol-dependent transactivation. Endocrinology 145 5515-5524.
16. Kitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, Matsui D, Ogawa S, Unno K, Okubo M, Tokita A et al. 2003 The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113 905-917.
17. Landrier JF, Thomas C, Grober J, Zaghini I, Petit V, Poirier H, Niot I & Besnard P 2005 The gene encoding the human ileal bile acid-binding protein (I-BABP) is regulated by peroxisome proliferator-activated receptors. Biochimica et Biophysica Acta 1735 41-49.
18. Lee HK, Lee YK, Park SH, Kim YS, Lee JW, Kwon HB, Soh J, Moore DD & Choi HS 1998 Structure and expression of the orphan nuclear receptor Shp gene. Journal of Biological Chemistry 273 14398-14402.
19. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J & Mangelsdorf DJ 2000 Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Molecular Cell 6 507-515.
20. Luo Z, Rouvinen J & Maenpaa PH 1994 A peptide C-terminal to the second Zn finger of human vitamin D receptor is able to specify nuclear localization. European Journal of Biochemistry 223 381-387.
21. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR & Mangelsdorf DJ 2002 Vitamin D receptor as an intestinal bile acid sensor. Science 296 1313-1316.
22. McKenna NJ & O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 465-474.
23. 3 1α-hydroxylase gene by parathyroid hormone, calcitonin, and 1α,25(Oh)2d3 in intact animals. Endocrinology 140 2224-2231.
24. Ogryzko VV, Schiltz RL, Russanova V, Howard BH & Nakatani Y 1996 The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 953-959.
25. Pineda Torra I, Freedman LP & Garabedian MJ 2004 Identification of DRIP205 as a coactivator for the farnesoid X receptor. Journal of Biological Chemistry 279 36184-36191.
26. Plass JR, Mol O, Heegsma J, Geuken M, Faber KN, Jansen PL & Muller M 2002 Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35 589-596.
27. Sakuma T, Miyamoto T, Jiang W, Kakizawa T, Nishio SI, Suzuki S, Takeda T, Oiwa A & Hashizume K 2003 Inhibition of peroxisome proliferator-activated receptor A signaling by vitamin D receptor. Biochemical and Biophysical Research Communications 312 513-519.
28. Sasaki S, Nakamura H, Tagami T, Miyoshi Y & Nakao K 1995 Functional properties of a mutant T3 receptor β (R338w) identified in a subject with pituitary resistance to thyroid hormone. Molecular and Cellular Endocrinology 113 109-117.
29. Savkur RS, Thomas JS, Bramlett KS, Gao Y, Michael LF & Burris TP 2005a Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1α. Journal of Pharmacology and Experimental Therapy 312 170-178.
30. Savkur RS, Bramlett KS, Stayrook KR, Nagpal S & Burris TP 2005b Coactivation of the human vitamin D receptor by the peroxisome proliferator-activated receptor γ coactivator-1 α. Molecular Pharmacology 68 511-517.
31. Sutton AL & MacDonald PN 2003 Vitamin D: more than a 'bone-a-fide' hormone. Molecular Endocrinology 17 777-791.
32. Thompson R & Strautnieks S 2001 BSEP: Function and role in progressive familial intrahepatic cholestasis. Seminars in Liver Disease 21 545-550.
33. 3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. Journal of Biological Chemistry 273 10338-10348.
34. 3 receptors. Cell 65 1255-1266.
35. Vogel A, Strassburg CP & Manns MP 2002 Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35 126-131.
36. Wagner M, Fickert P, Zollner G, Fuchsbichler A, Silbert D, Tsybrovskyy O, Zatloukal K, Guo GL, Schuetz JD, Gonzalez FJ et al. 2003 Role of farnesoid X receptor in determining hepatic Abc transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125 825-838.
37. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C et al. 2001 Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Molecular and Cellular Endocrinology 177 145-159.
38. Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ & Sharp HL 1994 Clinical and biochemical findings in progressive familial intrahepatic cholestasis. Journal of Pediatric Gastroenterology and Nutrition 18 134-141.
39. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA & Mangelsdorf DJ 1995 Lxr, a nuclear receptor that defines a distinct retinoid response pathway. Genes and Development 9 1033-1045.
40. Yanagisawa J, Kitagawa H, Yanagida M, Wada O, Ogawa S, Nakagomi M, Oishi H, Yamamoto Y, Nagasawa H, McMahon SB et al. 2002 Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Molecular Cell 9 553-562.
41. Yuan CX, Ito M, Fondell JD, Fu ZY & Roeder RG 1998 The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. PNAS 95 7939-7944.
42. Zhang Y, Ma K, Song S, Elam MB, Cook GA & Park EA 2004 Peroxisomal proliferator-activated receptor-γ coactivator-1 α (PGC-1 α) enhances the thyroid hormone induction of carnitine palmitoyltransferase I (CPT-I α). Journal of Biological Chemistry 279 53963-53971.